PCMS has successfully delivered the HCM Academy primary and secondary webinar series for 2023, now accessible on-demand via the HCM Academy website.
Brought to you by PCM Scientific, our CME division, the HCM Academy 2023 programme offers independent medical education, surrounding diagnosis and best practice care for patients with hypertrophic cardiomyopathy (HCM).
The primary and secondary care webinar series was accomplished with the support of our international faculty and steering committee members offering impactful education on diagnosis and best practice care and management of HCM.
The spectrum of topics covered was extensive, starting with fundamental ones like identifying HCM in primary care and progressing to an in-depth expert webinar aimed at aiding secondary healthcare professionals in understanding the detection and management of apical HCM.
The programme is developed in partnership with and endorsed by the HCMA, and was delivered to our community of primary and secondary care audiences including GPs, primary care nurses, cardiologists, interventional cardiologists, electrophysiologists, echocardiographers, and hospital pharmacists across the United States, Canada, and Europe, including the United Kingdom.
Engagement, learner feedback and education impact has been outstanding. 92% of attendees agreed they’ve gained knowledge that will ‘contribute to knowledge, skills, and attitude to enhance the delivery of patient care’ and 99% would recommend this education (event) to other healthcare providers.
The enduring assets are now available on the HCM Academy website until November 2024 for healthcare professionals to access and gain CE credit(s).